2 researchers in the laboratory

Infectious Disease Research and Funded Projects

Research Projects

Ryan White Project

The Ryan White HIV/AIDS Comprehensive AIDS Resources Emergency (CARE) Act began in 1990 as the first major effort to support and educate the growing number of HIV/AIDS patients in the U.S. The CARE Act is intended to help communities and states address unmet health needs of people living with HIV/AIDS by increasing the availability of primary care and support services.

Goals of the CARE Act are to reduce more costly inpatient care, increase access to care for underserved populations, and to improve the quality of life of those living with HIV/AIDS. The program is funded by the U.S. Department of Health and Human Services, Health Resources and Services Administration, and HIV/AIDS Bureau. The Ryan White Project currently funds the Division of Infectious Diseases' Bluegrass Care Clinic for Parts B, C, and D programs, which serves central and eastern Kentucky. For more information about the Ryan White CARE Act and what financial programs it offers, click here.

Vaccine and Drug Studies

Sponsors: Bavarian-Nordic, VIRxSYS, PaxVax

Principal Investigator: Richard Greenberg, MD

POEM (A4001067) Study: An International, Multicenter, Prospective Observational Study of the Saftey of Maraviroc Used with Optimized Background Therapy in Treatment-Experienced HIV-1 Infected Patients

Sponsor: ViiV Healthcare

Phase: Subjects are in the follow-up phase. Recruitment is closed.

*More information can be obtained at www.clinicaltrials.gov. Identifier: NCT00665561

Principal Investigator: Richard Greenberg, MD   859-323-6327

Study Coordinator: Heather Flynn, RN, CCRP, 859-323-3933

Cholera (PXVX-VC-200-004) Study: A Phase III Randomized, Double-blind, Placebo-controlled Three-Lot Consistency Study in Healthy Adult Volunteers (18-45) to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine

Sponsor: PaxVax, Inc.

Principal Investigator: Richard Greenberg, MD   859-323-6327

Study Coordinator: Beth Plummer, RN, CCRP, 859-323-5893

Cholera (PXVX-VC-200-005) Study: A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults (46-64) to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200, Vibrio Choler

Sponsor: PaxVax, Inc

Principal Investigator: Richard Greenberg, MD, 859-323-6327

Study Coordinator: Beth Plummer, RN, CCRP, 859-323-5893

T2 (DIREBT) Study: Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT Study) - Part 1 Prospective Collection and Freezing of Whole Blood Specimens

Sponsor: T2 Biosystems

* More information can be obtained at www.clinicaltrials.gov. Identifier: NCT01919762

Principal Investigator: Richard Greenberg, MD   859-323-6327

Study Coordinator: Heather Flynn, RN, CCRP, 859-323-3933

Clinical Research

Information about open clinical trials in infectious diseases at the University of Kentucky Chandler Medical Center and eligibility criteria will be posted here as they are approved by the University of Kentucky Medical Institutional Review Board.

HIV research opportunities are one of the many options for our Bluegrass Care Clinic patients and their plan of care. Dr. Greenberg and his study nurse, Heather Flynn, RN, have been working together since 2001. More information can be obtained by contacting Heather Flynn.

 

Heather Flynn, RN, CCRP

HIV Research Clinical Trial Coordinator
University of Kentucky
Office:  859-323-3933
Pager:  859-330-6634
hhvaug3@uky.edu

Faculty Interests

Epidemiology

Malkanthie McCormick, MBBS
Alice Thornton, MD
Martin Evans, MD

HIV/AIDS

Alice Thornton, MD
Richard Greenberg, MD
 Frank Romanelli, PharmD, MPH, BCPS

Vaccination and Antimicrobials

Richard Greenberg, MD
Brian Murphy, MD

Bioterrorism

Richard Greenberg, MD

Tuberculosis

Moises Huaman Joo, MD